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Abstract objective To determine rates of, and factors associated with, disengagement from care in a
decentralised antiretroviral programme.
methods Adults (≥16 years) who initiated antiretroviral therapy (ART) in the Hlabisa HIV
Treatment and Care Programme August 2004–March 2011 were included. Disengagement from care
was defined as no clinic visit for 180 days, after adjustment for mortality. Cumulative incidence
functions for disengagement from care, stratified by year of ART initiation, were obtained;
competing-risks regression was used to explore factors associated with disengagement from care.
results A total of 4,674 individuals (median age 34 years, 29% male) contributed 13 610 person-
years of follow-up. After adjustment for mortality, incidence of disengagement from care was 3.4 per
100 person-years (95% confidence interval (CI) 3.1–3.8). Estimated retention at 5 years was 61%.
The risk of disengagement from care increased with each calendar year of ART initiation (P for trend
<0.001). There was a strong association between disengagement from care and higher baseline CD4+
cell count (subhazard ratio (SHR) 1.94 (P < 0.001) and 2.35 (P < 0.001) for CD4+ cell count 150–
200 cells/ll and >200 cells/ll respectively, compared with CD4 count <50 cells/ll). Of those
disengaged from care with known outcomes, the majority (206/303, 68.0%) remained resident within
the local community.
conclusions Increasing disengagement from care threatens to limit the population impact of
expanded antiretroviral coverage. The influence of both individual and programmatic factors suggests
that alternative service delivery strategies will be required to achieve high rates of long-term retention.
keywords HIV-1, antiretroviral agents, primary health care, delivery of health care, lost to follow-
up, disengagement from care
Introduction
Long-term retention in human immunodeficiency virus
(HIV) care is one of the key challenges facing public
health systems in low-income and middle-income coun-
tries (Baggaley et al. 2012; World Health Organization
2012). This is especially true in South Africa, which has
rapidly expanded access to antiretroviral therapy (ART)
through the public health system since 2004 and now
operates the largest ART programme in the world (Joint
United Nations Programme on HIV/AIDS (UNAIDS)
(2012). The South African National Strategic Plan 2012–
2016 has a target of 80% overall retention at 5 years
(Department of Health 2011), yet there are few published
data on long-term retention. Here, we utilise linked longi-
tudinal data from a rural HIV treatment programme and
a demographic surveillance system to quantify rates of
disengagement from care, after adjustment of loss to
follow-up (LTF) for mortality, to explore the association
of disengagement from care with key individual, house-
hold and health system characteristics and finally to deter-
mine residency status for those disengaged from care.
Methods
Hlabisa HIV Treatment and Care Programme and Africa
Centre Demographic Information System (ACDIS)
The Hlabisa HIV Treatment & Care Programme
(HHTCP) delivers comprehensive HIV treatment and care
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in Hlabisa health subdistrict, northern KwaZulu-Natal
(Mutevedzi et al. 2010; Houlihan et al. 2011). Treatment
and care is devolved to 17 primary health care (PHC) clin-
ics and is delivered largely by nurses and counsellors in
adherence to national guidelines. All treatment and care is
provided free of charge. Clinical information is collected
at time of ART initiation for all individuals and is trans-
ferred from standardised paper-based clinic records to a
Microsoft SQL database housed at the Africa Centre.
Subsequent visits on ART and changes in vital status
(death, LTF, transfer out) are captured on paper-based
records and transferred to the database each month.
Since 2000, demographic data have been collected
from around 11 000 households and 85 000 individuals
in an area of 438 km2 situated within Hlabisa health
subdistrict (Tanser et al. 2008). An estimated 30–40%
of people in the HHTCP live in this area; six of the
17 PHC clinics are situated within the surveillance area.
Deaths of individuals classified as lost to follow-up from
the programme were identified through linkage of individ-
ual records between programme and surveillance databas-
es; in October 2011, a separate exercise was undertaken,
wherein additional deaths were identified through linkage
with the National Population Register (NPR).
Data analysis
This analysis included all adults (≥16 years) who were
members of the demographic surveillance system and ini-
tiated ART in the HHTCP between 1 August 2004 and
Table 1 Characteristics of 4674 adult members of the demo-
graphic surveillance who initiated antiretroviral therapy (ART)
n % (median) 95% CI (IQR)
Sex, male 1354 29.0 27.7–30.3
Age, years 4674 (34) (28–42)
Baseline CD4+ cell
count*, cells/ll
4477 (129) (67–182)
Year of ART initiation
2004–2006 760 16.3 15.2–17.4
2007 758 16.2 15.2–17.3
2008 1009 21.6 20.4–22.8
2009 882 18.9 17.8–20.2
2010 981 21.0 19.9–22.2
2011† 284 6.1 5.4–6.8
Current clinic‡
Township 1648 35.3 33.9–36.6
Town 663 14.2 13.2–15.2
Hospital 182 3.9 3.3–4.5
Rural clinics (914) 2181 46.7 45.2–48.1
Ever switched clinic
No 3432 87.6 86.6–88.7
Yes 372 9.5 8.6–10.4
Unknown 112 2.9 2.3–3.4
Transfer into the
programme
160 3.4 2.9–3.9
In-migration prior to
ART initiation
499 10.7 9.8–11.6
Number of days from
eligibility to initiation
4410 (49) (30–78)
Employed at initiation
No 1683 36.0 34.6–37.4
Yes 2361 50.5 49.1–52.0
Missing 630 13.5 12.5–14.5
Employed at last follow-up
No 2732 58.5 57.0–60.0
Yes 1650 35.3 33.9–36.7
Missing 292 6.3 5.6–6.9
Education (highest level achieved)
Secondary 2195 47.0 45.5–48.4
Primary 894 19.1 18.0–20.3
None 1203 25.7 24.5–27.0
Missing 382 8.2 7.4–9.0
Distance to nearest clinic, km
Median 3303 (2.3) (0.8–9.8)
>5 km 1278 38.7 37.0–40.4
Distance to nearest main tarred road (km)
Median 3303 (2.3) (0.8–9.8)
>5 km 1278 27.3 26.1–28.6
Marital status
Married 451 9.7 8.8–10.5
Never married 3580 76.8 75.6–78.0
Engaged 167 3.6 3.1–4.1
Divorced/widowed/
separated
463 9.9 9.1–10.8
(continued)
Table 1 (Continued)
n % (median) 95% CI (IQR)
Household owner
Self 1470 37.4 35.9–38.9
Spouse 244 6.2 5.4–7.0
Other 2220 56.4 54.9–58.0
Gender of household
owner, male
2059 54.0 52.5–55.6
Age of household owner 3810 (50) (41–60)
Number of individuals
in household
3859 (8) (5–12)
CI, confidence interval; IQR, interquartile range.
Figures in parentheses represent medians and interquartile ranges.
*Baseline CD4+ cell count defined as the last measured CD4+
cell count up to 180 days prior to date of ART initiation.
†Includes to 31 March 2011.
‡Although only six clinics are situated within the demographic
surveillance area, some members of the surveillance access clinics
outside the surveillance area but within the subdistrict.
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31 March 2011. In-migration prior to ART initiation
was defined as migration into the area in the 12 months
before the date of ART initiation. LTF was defined as
180 days having elapsed since the last recorded clinic
visit, in adherence to established definitions (Chi et al.
2011). Disengagement from care was defined as LTF
adjusted for mortality: individuals recorded as LTF who
were found, through linkage, to have died within
180 days of the last recorded clinic visit were reclassified
as deaths. Individuals who formally transferred care out
of the programme to another health facility were defined
as transfers out (TRO).
Observation started at date of ART initiation, or date of
transfer into programme for those already on ART, and
ended at date of death, date of last clinic visit (for LTF and
TRO) or database closure (12 July 2012). Cumulative inci-
dence functions for disengagement from care, stratified by
year of ART initiation and adjusted for all covariates in the
final multivariable model, were obtained using the Coviello
and Boggess method (Coviello & Boggess 2004). Overall
programme retention at 5 years was estimated from the
cumulative incidence curve. As disengagement from care
occurs in the context of competing risks of mortality and
transfers, competing-risks regression was used to explore
factors associated with disengagement (Bakoyannis &
Touloumi 2008; Gutierrez 2010). Individual and house-
hold socio-demographic characteristics, as well as geo-
graphical factors, were obtained from ACDIS with
reference to the last clinic visit date. The subhazard ratio
(SHR) was derived as the risk of disengagement for indi-
viduals in a certain category compared with a reference
category, in the presence of competing risks of death and
transfer out. All analyses were conducted using STATA
11.2 (StataCorp, College Station, Texas), and all results
are reported at 5% significance level.
Ethics statement
Ethical approval was granted by the Biomedical Research
Ethics Committee of the University of KwaZulu-Natal
(refs. BE066/07 & E134/06) and the Health Research
Committee of the KwaZulu-Natal Department of Health
(refs. HRKM012/07 & HRKM032/08).
Results
Cohort characteristics
A total of 4674 adult members of the demographic sur-
veillance system initiated ART between 1 August 2004
and 31 March 2011 (Table 1) and contributed 13 610
person-years of follow-up (median 2.77 years).
Disengagement from care
Overall, 676 (14.5%) died, 260 (5.6%) transferred out of
the programme, 558 (11.9%) were LTF, and 3180
(68.0%) were alive on ART (Figure 1). Of those LTF, 91
(16.3%) had died within 180 days of their last clinic visit
[median time 7 days, interquartile range (IQR) 0–36].
Consequently, the true mortality was 16.4% (n = 767)
and the proportion disengaged from care was 10.0%
(n = 467); the rate of disengagement was 3.4 per 100
person-years [95% confidence interval (CI) 3.1–3.8].
After adjustment for mortality, the first 3 months post-
ART initiation remained the period with the highest rate
of disengagement (Table 2). The rate of disengagement
increased for each calendar year of ART initiation
(Figure 2). Overall programme retention at 5 years
was estimated at 61%.
Factors associated with disengagement from care
There was a significant trend in increasing risk of dis-
engagement from care with increasing baseline CD4+
cell count: SHR 1.56, 1.75, 1.94 and 2.35 for CD4+
cell count 50–99, 100–149, 150–200 and >200 cells/ll,
respectively, compared with CD4 count <50 cells/ll
(Figure 3). Year of ART initiation was strongly
associated with disengagement from care, with risk
progressively increasing with each calendar year
(P < 0.002 across all years). Individuals who had
migrated into the AC surveillance area in the year
prior to ART initiation were 53% more likely to disen-
gage from care compared with those resident through-
out (SHR 1.53, P = 0.03).
Outcomes after disengagement from care
Of the 467 individuals disengaged from care, most (303,
65.9%) had surveillance data available beyond 180 days
from last clinic visit. The majority (206/303, 68.0%)
remained resident within the surveillance area, whereas
97 (32.0%) had migrated outside the surveillance area
(median time from last clinic visit to migration 2 days,
IQR 2–157). Overall, 24 individuals died subsequent to
disengagement, a median of 455 days (IQR 287–590)
after their last clinic visit.
Discussion
In South Africa, the rapid scale-up of HIV treatment pro-
grammes has put enormous strain on health systems,
especially in rural areas, where health systems remain
critically under-resourced (Versteeg & Couper 2011).
936 © 2013 John Wiley & Sons Ltd
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The programme reported here has rapidly expanded ART
coverage resulting in positive impacts on population-level
mortality and on risk of HIV acquisition (Herbst et al.
2009; Cooke et al. 2010; Mutevedzi et al. 2010; Bor
et al. 2013; Tanser et al. 2013). Increasing disengage-
ment from care has the potential to limit these gains, and
LTF, lost to follow-up; DSA, Demographic Surveillance Area
* Unknown status refers to individuals for whom there is no surveillance data from after
the LTF reference date (last clinic visit + 180 days)
 Median time to death for these 24 deaths was 455 days (IQR 287-590)
 from last clinic visit
Demographic Surveillance System
4674 members of Africa Centre
3180 (68.0%) active on treatment
676 (14.5%) deceased
260 (5.6%) transferred out
558 (11.9%) LTF after ART
91/558 (16.3%) died within 180
467/558 (83.7%)
disengaged from care
164/467 (35.1%) unknown status at
206/303 (68.0%) alive and 97/303 (32.0%)
20/206 (9.7%) subsequently      4/97 (4.1%)
 subsequently dieddied
migrated out of DSA
within 180 days of last
clinic visit
resident in DSA at 180
days
180 days*
days of last clinic visit
initiation
initiated ART August 2004 – March
2011
Figure 1 Flow diagram of 4674
individuals from time of ART initiation to
determination of vital status after
disengagement from care.
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these data highlight the need to develop successful long-
term retention strategies.
Overall programme retention at 5 years was estimated
at 61%, below the target of 80% in the National Strate-
gic Plan (Department of Health 2011). There are limited
data on long-term retention, and this is the first report
with long-term follow-up from a rural PHC programme.
A combined analysis of eight urban public sector ART
programmes reported overall programme retention of
64% at 3 years (Cornell et al. 2010), whereas two indi-
vidual programmes reported combined LTF and mortality
at 5 and 6 years, respectively, of 35.3% and 37.4%
(Boulle et al. 2010; Nglazi et al. 2011). Our estimated
retention at 5 years of 61% is broadly comparable to
these studies, suggesting there may be relatively limited
heterogeneity in programmatic performance.
The finding that disengagement from care has increased
with each year of programme scale-up is of major
concern: individuals enrolled on ART in 2010 and 2011
had more than double the risk of disengagement
compared with those enrolled in 2004–2006. This sup-
ports findings from other programmes (Boulle et al.
2010; Fatti et al. 2011; Nglazi et al. 2011), although
only one had corrected LTF for mortality (Boulle et al.
2010). This may reflect health systems struggling to cope
with increasing patient load. In this programme, service
delivery has been devolved to PHC level since inception
in 2004, so whether models of care with further decen-
tralisation outside the health system into the community
could improve long-term retention should be evaluated
(Decroo et al. 2011; Fatti et al. 2012; Rich et al. 2012).
With moves towards earlier initiation of ART and the
expanded use of treatment for prevention, concern has
been raised about whether adherence and retention will
be different in those who are less symptomatic at the
time of ART initiation (Lockman & Sax 2012). In this
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Figure 2 Rates of disengagement from
care, stratified by calendar year of
antiretroviral therapy initiation.
Table 2 Rates of loss to follow-up (LTF) and disengagement from care (after adjustment of LTF for mortality), per 100 person-years
Cohort period
(months) Person-time
Loss to follow-up Disengagement from care
Failures Rate 95% CI Failures Rate 95% CI
0–3 1113.62 91 8.17 6.65–10.04 58 5.21 4.03–6.74
3–12 3076.44 121 3.93 3.29–4.70 99 3.22 2.64–3.92
12–24 3486.20 127 3.64 3.06–4.33 112 3.21 2.67–3.87
24–36 2538.28 97 3.82 3.13–4.66 86 3.39 2.74–4.19
36 3395.74 122 3.59 3.01–4.29 112 3.30 2.74–3.97
Total 13610.28 558 4.10 3.77–4.45 467 3.43 3.13–3.76
CI, confidence interval.
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light, the association between higher pre-treatment CD4+
cell count and increasing disengagement is of concern.
Mathematical models exploring HIV treatment for pre-
vention have demonstrated that the impact on HIV inci-
dence is particularly sensitive to changes in programme
retention but have assumed low rates of disengagement,
based on data from the early phase of treatment scale-up,
which may not reflect the current situation (Granich
et al. 2009; Hontelez et al. 2011; Eaton et al. 2012).
There are high levels of population mobility in this
rural area, and migration dynamics are complex (Muhw-
ava et al. 2010). About one in ten people who initiated
ART in this programme had migrated into the area in the
year before ART initiation, consistent with our previous
findings that people return to the family home when
unwell and to access ART (Welaga et al. 2009; Olgiati
et al. 2012). These in-migrants were more likely to disen-
gage after ART initiation, which may partially reflect
people returning to employment (Bor et al. 2012). The
highest rates of disengagement from care were observed
in the first 3 months after ART initiation. Disengagement
during this early time period could also be explained by
early morbidity, drug toxicity or problems with the
patient/provider relationship at the healthcare facility.
These early losses, combined with early mortality, high-
light that the first few months after ART initiation
remain a critical period when more intensive support
might be required, and it may be that programmes are
increasingly unable to provide that extra support.
Interpretation of these results should be subject to
some limitations. The reclassification of deaths included
those who died within 180 days of last clinic visit. This
is a relatively long time period and therefore might
encompass some people who disengaged from care and
died as a result of ART interruption, thus underestimat-
ing true disengagement from care and its impact. How-
ever, the median time to death for those reclassified was
7 days and almost three-quarters died within a month of
the last clinic visit, suggesting that most deaths occurred
before the next scheduled clinic visit. We were unable to
identify individuals that disengaged but then reengaged
with care, an occurrence that has been reported to be
*Time updated CD4 count refers to last recorded CD4 count prior to meeting endpoint or prior to censoring.
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Figure 3 Subhazard ratios for disengagement from care in the presence of competing risks of mortality and transfer out. Model
adjusted for education level and employment as at time of last clinic visit.
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quite frequent elsewhere (Kranzer et al. 2010). Failure to
capture these interruptions in care could underestimate
the potential impact of disengagement on both individual-
and population-level outcomes. The additional support
provided by a non-governmental organisation might
contribute to differences in programmatic outcomes, so
this cannot necessarily be taken to be truly representative
of all public sector programmes.
In summary, increasing rates of disengagement from
care underline the need for new service delivery strategies
to achieve the high rates of long-term retention needed to
sustain the positive impacts of ART roll-out.
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